One major biotech investor just walked away from Viking Therapeutics. Here’s what the move may—and may not—mean for the ...
A leading scientist from San Francisco-based biotech firm Mammoth Biosciences told the Dubai Future Forum today that the ...
Having found swift success with its Jazz Pharmaceuticals and BeOne Medicines-licensed cancer med Ziihera, Zymeworks has ...
Pennsylvania’s short-term politics threaten its biotech future, driving innovation and opportunity to rival states.
Even newer “minimally invasive” ideas, like stent-mounted electrodes deployed through blood vessels, still require a catheter ...
The food biotechnology market is projected to grow substantially over the next decade, rising from an estimated USD 32.5 ...
On November 10, 2025, The Fly reported that H.C. Wainwright increased its price target on Vera Therapeutics, Inc.
Students, industry leaders and government officials gathered at UCLA’s California NanoSystems Institute to learn about the future of biotechnology on Nov. 8. Biotech Connection Los Angeles – a ...
What do agriculture and genetics have in common? We sat down with PhD candidate Harrison Estes to learn more about his unique ...
Ecuadorian scientists are developing a biotechnological strategy to stop banana wilt by genetically editing the causative ...
From plastic-eating plants to AI-guided therapies, iGEM 2025 reveals the innovations defining the future of synthetic biology ...
ReNerve (ASX:RNV) is a cutting-edge biotech developing “ready-to-use” products for nerve repair and regeneration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback